Tumour Characteristics and Surgical Treatment of Renal Cell Carcinoma in Sweden 2005-2010: a Population-based Study from the National Swedish Kidney Cancer Register
Overview
Authors
Affiliations
Objective: Tumour characteristics, preoperative work-up and surgical treatment in patients diagnosed with renal cell carcinoma (RCC) between 2005 and 2010, and changes over time were studied in a national population-based cohort.
Material And Methods: The National Swedish Kidney Cancer Register (NSKCR) contains information on histopathology, Fuhrman grade and clinical stage at presentation, and on the preoperative work-up and surgical treatment of patients with RCC. Between 2005 and 2010, 5553 RCC patients were registered in the NSKCR, 99% of those registered in the National Cancer Registry.
Results: During the study period the mean tumour size decreased from 70 to 64 mm (p = 0.024) and the frequency of metastatic RCC decreased from 22% to 15% (p < 0.001). The use of preoperative chest computed tomography increased from 59% to 84%. In total, 4229 (76%) patients were treated with curative intent, 3453 (82%) underwent radical nephrectomy, 606 (14%) partial nephrectomy (PN) and 170 (4%) cryotherapy or radiofrequency ablation. In tumours up to 4 cm, PN was performed in 33% of the surgically treated patients. PN irrespective of size increased from 8% to 20% and laparoscopic nephrectomy increased from 6% to 17% during the period. In patients with metastatic RCC, 55% underwent cytoreductive nephrectomy.
Conclusions: The NSKCR explores population-based data on the clinical handling of patients with RCC. This study, between 2005 and 2010, shows significant decrease in tumour size and metastatic RCC at presentation, a more complete preoperative work-up, and significantly increased use of PN and laparoscopic nephrectomy in Sweden.
Jozwik-Plebanek K, Saracyn M, Kolodziej M, Kaminska O, Durma A, Madra W Pharmaceuticals (Basel). 2025; 17(12.
PMID: 39770563 PMC: 11678666. DOI: 10.3390/ph17121721.
Chandramohan D, Garapati H, Nangia U, Simhadri P, Lapsiwala B, Jena N Front Med (Lausanne). 2024; 11:1447057.
PMID: 39301494 PMC: 11412207. DOI: 10.3389/fmed.2024.1447057.
Sudarevic B, Pavokovic D, Slobodanac E Acta Clin Croat. 2024; 62(Suppl2):84-94.
PMID: 38966018 PMC: 11221236. DOI: 10.20471/acc.2023.62.s2.12.
Penaranda N, Eissa A, Ferretti S, Bianchi G, Di Bari S, Farinha R Diagnostics (Basel). 2023; 13(19).
PMID: 37835812 PMC: 10572445. DOI: 10.3390/diagnostics13193070.
Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century.
Tichanek F, Forsti A, Hemminki A, Hemminki O, Hemminki K Cancers (Basel). 2023; 15(10).
PMID: 37345119 PMC: 10216153. DOI: 10.3390/cancers15102782.